DJIA 16,960.57 -123.23 -0.72%
NASDAQ 4,449.56 -22.54 -0.50%
S&P 500 1,978.34 -9.64 -0.48%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

3.16 -0.10 (-3.07%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ZIOP $3.16 -3.07%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.23
Previous Close $3.26
Daily Range $3.15 - $3.25
52-Week Range $2.75 - $5.58
Market Cap $318.3M
P/E Ratio -5.34
Dividend (Yield) $0.00 (0.0%)
Volume 462,080
Average Daily Volume 757,167
Current FY EPS -$0.38

Sector

Healthcare

Industry

Drugs

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary Rss Feed

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind

Myraid Genetics, Sarepta Therapeutics, Questcor Pharmaceuticals, Ziopharm Oncology, and MannKind top the list of the most shorted biotechs.

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update

Why Ziopharm Looks Worth Adding To Your Biotechnology Portfolio Pipeline

The Sirens Of Ziopharm

Can the Uptrend Continue for ZIOPHARM (ZIOP)? - Tale of the Tape

Mid-Morning Market Update: Markets Gain On Jobs Data; VeriFone Earnings Beat Estimates

Ziopharm - A Stock Worth Owning To Benefit Your Portfolio This Year And Beyond

ZIOPHARM Presents Encouraging Data - Analyst Blog

Comparison Shopping For Small-Cap Biotech Deals

Ophthotech (OPHT) Jumps: Stock Rises 24.5% - Tale of the Tape

Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $3.16 (-3.07%)
Current stock: ZIOP
AMGN $122.84 (0.47%)
Current stock: AMGN
GILD $89.84 (-0.77%)
Current stock: GILD
BIIB $335.45 (-0.40%)
Current stock: BIIB